These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33776431)

  • 1. Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.
    Bian S; Cai H; Cui Y; Liu W; Xiao C
    Int J Nanomedicine; 2021; 16():2247-2269. PubMed ID: 33776431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome.
    Xu Y; Lv L; Wang Q; Yao Q; Kou L; Zhang H
    Colloids Surf B Biointerfaces; 2024 May; 237():113869. PubMed ID: 38522285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.
    Wang YY; Li XZ; Wang LB
    Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome.
    Zhuang C; Kang M; Lee M
    J Control Release; 2023 Aug; 360():1-14. PubMed ID: 37330013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome.
    Galvin IM; Steel A; Pinto R; Ferguson ND; Davies MW
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003707. PubMed ID: 23881653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the use of exosomes for the treatment of ALI/ARDS.
    Liu C; Xiao K; Xie L
    Front Immunol; 2022; 13():971189. PubMed ID: 36016948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review: gene-based therapies for ALI/ARDS: where are we now?
    Devaney J; Contreras M; Laffey JG
    Crit Care; 2011; 15(3):224. PubMed ID: 21699743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome.
    Liu Y; Wang X; Li P; Zhao Y; Yang L; Yu W; Xie H
    Respir Med; 2020 Dec; 175():106210. PubMed ID: 33197806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel interventional approaches for ALI/ARDS: cell-based gene therapy.
    Zhu YG; Qu JM; Zhang J; Jiang HN; Xu JF
    Mediators Inflamm; 2011; 2011():560194. PubMed ID: 21785528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel application of nanomedicine for the treatment of acute lung injury: a literature review.
    Chen X; Tang Z
    Ther Adv Respir Dis; 2024; 18():17534666241244974. PubMed ID: 38616385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of mechanosensitive ion channels in acute lung injury/acute respiratory distress syndrome.
    Jia Q; Yang Y; Chen X; Yao S; Hu Z
    Respir Res; 2022 Dec; 23(1):366. PubMed ID: 36539808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS.
    Liu C; Xiao K; Xie L
    Front Immunol; 2022; 13():922702. PubMed ID: 36059534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for ALI/ARDS.
    Lin X; Dean DA
    Crit Care Clin; 2011 Jul; 27(3):705-18. PubMed ID: 21742224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
    Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles in the pathogenesis and treatment of acute lung injury.
    Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH
    Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential.
    Vichare R; Janjic JM
    Inflammation; 2022 Dec; 45(6):2124-2141. PubMed ID: 35641717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.
    Li J; Huang S; Wu Y; Gu C; Gao D; Feng C; Wu X; Fu X
    Int Wound J; 2014 Apr; 11(2):114-21. PubMed ID: 24373614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment.
    Matuschak GM; Lechner AJ
    Mo Med; 2010; 107(4):252-8. PubMed ID: 20806836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice.
    Wakayama H; Hashimoto N; Matsushita Y; Matsubara K; Yamamoto N; Hasegawa Y; Ueda M; Yamamoto A
    Cytotherapy; 2015 Aug; 17(8):1119-29. PubMed ID: 26031744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment.
    Liu C; Xiao K; Xie L
    Front Immunol; 2022; 13():928134. PubMed ID: 35880175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.